STOCK TITAN

Inogen Inc - INGN STOCK NEWS

Welcome to our dedicated page for Inogen news (Ticker: INGN), a resource for investors and traders seeking the latest updates and insights on Inogen stock.

Inogen Inc. (INGN) is a pioneering medical technology company committed to enhancing the quality of life for supplemental oxygen users. Founded in 2001, Inogen emerged from a personal story of necessity and innovation. The company's mission began when Mae, the grandmother of one of the founders, was prescribed oxygen therapy, highlighting the need for more user-friendly and portable oxygen solutions. You can learn more about Mae's story here.

Inogen aims to revolutionize oxygen therapy technology, striving to keep pace with the active lifestyles of patients who rely on oxygen to lead fulfilling lives. The company estimates that over 2.5 million patients in the United States and more than 4.5 million patients worldwide use oxygen therapy.

The company's flagship product, the Inogen One system, is a compact, lightweight, and travel-approved portable oxygen concentrator designed to liberate patients from the constraints of heavy tanks, frequent refills, and stationary systems. This innovation provides patients with the freedom and independence to live their lives by moments, not by the minutes left in an oxygen tank.

Inogen's products and services are sold through various channels, including home medical equipment providers, distributors, large gas companies, and home oxygen providers. The company also rents its products directly to patients, generating the majority of its revenue within the United States.

Inogen's commitment to continuous improvement is evident in its ongoing projects and recent achievements. The company constantly works toward refining its product offerings and expanding its reach to benefit more patients globally.

Rhea-AI Summary
Inogen, Inc. (INGN) will report its first quarter 2024 financial results on May 7, 2024, followed by a conference call. The call will be accessible via phone and webcast. The company emphasizes transparency by archiving the call and providing a replay option.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.15%
Tags
conferences earnings
-
Rhea-AI Summary
Inogen, Inc. (INGN) to participate in the 23rd Annual Needham Virtual Healthcare Conference. Kevin Smith and Michael Bourque to discuss innovative respiratory products. Webcast available for interested parties.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.36%
Tags
conferences
-
Rhea-AI Summary
Inogen, Inc. announced the approval of restricted stock units as a material inducement for Michael Bourque, the new Executive Vice President, Chief Financial Officer, and Treasurer. The equity awards consist of 75,000 time-based RSUs and 75,000 performance-based PSUs, potentially reaching a maximum of 150,000 PSUs. The awards are subject to vesting based on Mr. Bourque's continued service and Inogen's performance goals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.66%
Tags
none
Rhea-AI Summary
Inogen, Inc. (INGN) reported fourth-quarter 2023 revenue of $75.9 million and full-year 2023 revenue of $315.7 million. The company highlighted a focus on revenue growth, profitability, and innovation in 2024. Notable financial results included a decrease in total revenue due to lower business-to-business and direct-to-consumer sales, offset by higher rental revenue. The company reported a GAAP net loss of $26.6 million for Q4 2023 and $102.4 million for full-year 2023. Adjusted net loss was $19.4 million for Q4 2023 and $48.3 million for full-year 2023. Inogen expects first-quarter 2024 revenue of $73 to $74 million, representing 1% to 3% growth compared to Q1 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-32.66%
Tags
-
Rhea-AI Summary
Inogen, Inc. (INGN) will report Q4 and full year 2023 financial results on February 27, 2024. A conference call and webcast will be hosted the same day. The call will be accessible through dial-in and webcast, with a replay available for three hours after the live webcast ends. Inogen uses its Investor Relations website to disclose material non-public information and comply with disclosure obligations under Regulation FD.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.31%
Tags
conferences earnings
-
Rhea-AI Summary
Inogen, Inc. (Nasdaq: INGN) has appointed Michael Bourque as the new Chief Financial Officer, effective March 4, 2024. Bourque brings extensive experience from his roles at Chase Corporation, Keystone Dental, Analogic Corporation, and Axcelis Technologies. Inogen's President and CEO, Kevin Smith, expressed excitement over Bourque's appointment, highlighting his ability to help the company continue delivering superior respiratory solutions. The former Interim CFO, Mike Sergesketter, will remain in an advisory role during the transition. Bourque's appointment marks a pivotal point in Inogen's story, with a focus on delivering value to patients and shareholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.82%
Tags
none
Rhea-AI Summary
Inogen, Inc. (NASDAQ: INGN) appoints Kevin Smith as President and CEO, bringing over 20 years of medical device industry experience, aiming to drive growth and organizational transformation. The company reaffirms its full year financial guidance and announces its non-attendance at upcoming healthcare conferences.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.21%
Tags
management
-
Rhea-AI Summary
Inogen, Inc. (INGN) to present at Stifel 2023 Healthcare Conference and Piper Sandler 35th Annual Healthcare Conference. The live webcast will be available on the Inogen Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.68%
Tags
conferences
-
Rhea-AI Summary
Inogen, Inc. (Nasdaq: INGN) Announces Q3 2023 Financial Results, Reports $84.0 Million in Total Revenue, a 20.3% Decrease from Q3 2022
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.14%
Tags
Rhea-AI Summary
Inogen, Inc. will report Q3 2023 financial results on November 7, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.8%
Tags
conferences earnings

FAQ

What is the current stock price of Inogen (INGN)?

The current stock price of Inogen (INGN) is $10.11 as of December 2, 2024.

What is the market cap of Inogen (INGN)?

The market cap of Inogen (INGN) is approximately 237.4M.

What does Inogen Inc. do?

Inogen Inc. develops and manufactures portable oxygen concentrators to deliver oxygen therapy for patients with chronic respiratory conditions.

What is Inogen's flagship product?

Inogen's flagship product is the Inogen One system, a compact and lightweight portable oxygen concentrator.

How does Inogen sell its products?

Inogen sells its products through home medical equipment providers, distributors, large gas companies, and home oxygen providers. They also rent products directly to patients.

Where does Inogen generate most of its revenue?

Inogen generates the majority of its revenue in the United States.

How many patients use oxygen therapy according to Inogen?

Inogen estimates that more than 2.5 million patients in the United States and over 4.5 million patients worldwide use oxygen therapy.

What makes Inogen's products stand out?

Inogen's products, like the Inogen One system, are designed to be compact, lightweight, and travel-approved, freeing patients from heavy tanks and stationary systems.

What is the mission of Inogen Inc.?

Inogen's mission is to improve the quality of life for supplemental oxygen users by providing innovative and user-friendly oxygen therapy solutions.

Who inspired the founding of Inogen?

Inogen was inspired by Mae, the grandmother of one of the founders, who was prescribed oxygen therapy and needed a more convenient solution.

Where can I learn more about Inogen's history?

You can learn more about Inogen's history and inspiration behind its founding on their website at http://www.inogen.com/about-inogen/meet-mae/.

What is Inogen Inc.'s stock symbol?

Inogen Inc. is publicly traded with the stock symbol INGN.

Inogen Inc

Nasdaq:INGN

INGN Rankings

INGN Stock Data

237.35M
23.39M
1.78%
89.84%
3.13%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States of America
GOLETA